Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

GTBPGT Biopharma, Inc.

Nasdaq · CIK 0000109657
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts416

Identity from submissions API

NameGT Biopharma, Inc.
CIK0000109657
TickersGTBP
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN941620407
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(800) 304-9888
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • GT Biopharma, Inc. (2017-08-11T04:00:00.000Z → 2026-11-16T05:00:00.000Z)
  • OXIS INTERNATIONAL INC (1995-06-08T04:00:00.000Z → 2017-07-25T04:00:00.000Z)
Business address
505 MONTGOMERY STREET
10TH FLOOR
SAN FRANCISCO
CA
94111
CA
Mailing address
505 MONTGOMERY STREET
10TH FLOOR
SAN FRANCISCO
CA
94111
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

885 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 10-Q 10-Q 0001493152-26-052327 001-40023 261560208 34 8519776 1 1
2026-11-12 8-K 8-K 5.07,9.01 0001493152-26-051221 001-40023 261543613 34 229202 1 1
2026-10-20 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-003305 333-299408 261474064 33 2062
2026-10-20 424B3 424B3 0001493152-26-047792 333-299408 261473665 33 389715
2026-10-13 DEF 14A DEF 14A 0001493152-26-046861 001-40023 261457526 34 1118241
2026-10-09 S-1 S-1 0001493152-26-046618 333-299408 261453806 33 957034 1 1
2026-10-02 PRE 14A PRE 14A 0001493152-26-045611 001-40023 261438017 34 1116957
2026-09-29 D xslFormDX01/primary_doc.xml 06b 0000109657-26-000001 021-599201 261421459 33 9775
2026-09-25 8-K 8-K 8.01,9.01 0001493152-26-044309 001-40023 261410478 34 204179 1 1
2026-09-21 8-K 8-K 1.01,3.02,3.03,5.03,9.01 0001493152-26-043562 001-40023 261394052 34 296618 1 1
2026-09-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001213900-26-100247 005-32837 261382103 34 7302
2026-09-15 8-K 8-K 1.01,3.02,3.03,5.03,9.01 0001493152-26-042672 001-40023 261379250 34 1465373 1 1
2026-09-03 8-K 8-K 3.03,5.03,8.01,9.01 0001493152-26-041333 001-40023 261357291 34 398678 1 1
2026-08-14 8-K 8-K 5.07,9.01 0001493152-26-038446 001-40023 261282566 34 227728 1 1
2026-08-14 10-Q 10-Q 0001493152-26-037988 001-40023 261276251 34 7975695 1 1
2026-07-02 DEF 14A DEF 14A 0001493152-26-031922 001-40023 261151882 34 3353166 1 1
2026-06-18 PRE 14A PRE 14A 0001493152-26-029362 001-40023 261103456 34 3334685 1 1
2026-06-12 8-K 8-K 5.03,9.01 0001493152-26-028457 001-40023 261087248 34 221248 1 1
2026-05-22 8-K 8-K 3.01,9.01 0001493152-26-024913 001-40023 261010805 34 205874 1 1
2026-05-15 10-Q 10-Q 0001493152-26-023346 001-40023 26982379 34 5344356 1 1
2026-05-13 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001620 333-295461 26975626 33 2061
2026-05-13 424B3 424B3 0001493152-26-022795 333-295461 26974643 33 342930
2026-05-11 CORRESP filename1.htm 0001493152-26-022183 13456
2026-05-06 UPLOAD filename1.pdf 0000000000-26-004634 333-295461 147113
2026-04-30 S-1 S-1 0001493152-26-020697 333-295461 26926748 33 791317 1 1
2026-04-07 8-K 8-K 1.01,9.01 0001493152-26-015413 001-40023 26842894 34 427865 1 1
2026-03-06 10-Q/A 10-Q/A 0001493152-26-009127 001-40023 26730738 34 8259051 1 1
2026-03-06 10-Q/A 10-Q/A 0001493152-26-009126 001-40023 26730736 34 7411248 1 1
2026-03-02 10-K 10-K 0001493152-26-008443 001-40023 26703430 34 8962507 1 1
2026-03-02 8-K 8-K 4.02,9.01 0001493152-26-008442 001-40023 26703424 34 280352 1 1
2026-01-30 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000420 333-292856 26585509 33 2061
2026-01-30 424B3 424B3 0001493152-26-004547 333-292856 26584504 33 347867
2026-01-28 CORRESP filename1.htm 0001493152-26-003958 13330
2026-01-27 UPLOAD filename1.pdf 0000000000-26-000990 333-292856 40332
2026-01-21 S-1 S-1 0001493152-26-003089 333-292856 26547985 33 995547 1 1
2026-01-08 424B3 424B3 0001493152-26-000976 333-287963 26519839 33 10192
2025-12-02 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003476 333-291060 251544903 33 2062
2025-12-02 424B3 424B3 0001493152-25-025796 333-291060 251544218 33 314333
2025-12-02 CORRESP filename1.htm 0001493152-25-025711 12962
2025-11-26 8-K 8-K 3.01,9.01 0001493152-25-025162 001-40023 251530814 34 207668 1 1
2025-11-14 10-Q 10-Q 0001493152-25-023400 001-40023 251485498 34 6524570 1 1
2025-11-14 8-K 8-K 2.02,9.01 0001493152-25-022631 001-40023 251481678 34 238780 1 1
2025-10-24 S-1 S-1 0001493152-25-019296 333-291060 251416395 33 1112537 1 1
2025-09-26 8-K 8-K 3.03,9.01 0001493152-25-015725 001-40023 251350794 34 204211 1 1
2025-09-23 8-K 8-K 3.03,9.01 0001493152-25-014684 001-40023 251334744 34 222692 1 1
2025-09-08 4 xslF345X05/ownership.xml 0001641172-25-026893 5604
2025-09-08 4 xslF345X05/ownership.xml 0001641172-25-026890 10115
2025-09-08 4 xslF345X05/ownership.xml 0001641172-25-026894 7903
2025-09-08 4 xslF345X05/ownership.xml 0001641172-25-026891 5573
2025-09-08 4 xslF345X05/ownership.xml 0001641172-25-026892 5589
2025-08-29 8-K 8-K 5.02,9.01 0001493152-25-012479 001-40023 251281054 34 230559 1 1
2025-08-14 10-Q 10-Q 0001493152-25-011971 001-40023 251218435 34 7489173 1 1
2025-07-30 3 xslF345X02/ownership.xml 0001641172-25-021546 3273
2025-07-24 8-K 8-K 5.07 0001641172-25-020847 001-40023 251147488 34 226178 1 1
2025-07-03 424B3 424B3 0001641172-25-017705 333-287963 251103830 33 482007
2025-07-02 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002145 333-287963 251103655 33 2062
2025-07-01 CORRESP filename1.htm 0001641172-25-017364 13462
2025-06-27 S-1/A S-1/A 0001641172-25-016977 333-287963 251088086 33 1125557 1 1
2025-06-27 CORRESP filename1.htm 0001641172-25-016958 110029
2025-06-20 UPLOAD filename1.pdf 0000000000-25-006479 333-287963 43632
2025-06-11 S-1 S-1 0001641172-25-014752 333-287963 251040999 33 1131078 1 1
2025-06-11 DEFA14A DEFA14A 0001641172-25-014722 001-40023 251040479 34 1179109
2025-06-11 DEF 14A DEF 14A 0001641172-25-014721 001-40023 251040457 34 2730646 1 1
2025-06-11 8-K 8-K 1.01,5.02,9.01 0001641172-25-014700 001-40023 251039943 34 252764 1 1
2025-06-03 3 xslF345X02/ownership.xml 0001641172-25-013435 3258
2025-06-02 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001683168-25-004168 005-32837 251016837 34 14249
2025-05-30 PRE 14A PRE 14A 0001641172-25-013033 001-40023 251011002 34 2886443 1 1
2025-05-29 3 xslF345X02/ownership.xml 0001641172-25-012862 3306
2025-05-28 D xslFormDX01/primary_doc.xml 06b 0001641172-25-012695 021-547407 25995591 33 9830
2025-05-27 8-K 8-K 1.01,3.02,3.03,5.03,9.01 0001641172-25-012481 001-40023 25988591 34 304086 1 1
2025-05-27 D xslFormDX01/primary_doc.xml 06b 0001641172-25-012480 021-547250 25988576 33 9642
2025-05-15 10-Q 10-Q 0001641172-25-010790 001-40023 25952007 34 7106672 1 1
2025-05-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-25-043005 005-32837 25943050 34 7260
2025-05-13 8-K 8-K 5.02 0001641172-25-009941 001-40023 25939930 34 207621 1 1
2025-05-13 8-K 8-K 1.01,3.02,3.03,5.03,9.01 0001641172-25-009854 001-40023 25937444 34 1333716 1 1
2025-05-05 8-K 8-K 5.02 0001641172-25-008682 001-40023 25912868 34 205274 1 1
2025-04-14 10-K/A form10-ka.htm 0001641172-25-004563 001-40023 25836050 34 641273 1 1
2025-04-04 8-K form8-k.htm 3.02,9.01 0001641172-25-002750 001-40023 25813982 34 356530 1 1
2025-03-14 424B3 form424b3.htm 0001493152-25-010276 333-285618 25737808 33 199234
2025-03-13 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000665 333-285618 25737480 33 2068
2025-03-11 CORRESP filename1.htm 0001493152-25-009853 12517
2025-03-11 UPLOAD filename1.pdf 0000000000-25-002658 333-285618 40459
2025-03-07 D xslFormDX01/primary_doc.xml 06b 0000109657-25-000002 021-540228 25721363 33 11419
2025-03-06 S-3 forms-3.htm 0001493152-25-009422 333-285618 25716398 33 501504
2025-02-26 8-K form8-k.htm 1.01,3.02,9.01 0001493152-25-008387 001-40023 25671246 34 632068 1 1
2025-02-24 RW formrw.htm 0001493152-25-007976 333-284032 25654271 NE 13651
2025-02-21 10-K form10-k.htm 0001493152-25-007908 001-40023 25652918 34 8539632 1 1
2025-02-07 S-1/A forms-1a.htm 0001493152-25-005314 333-284032 25599603 33 1881635
2025-01-27 S-1/A forms-1a.htm 0001493152-25-003718 333-284032 25555832 33 2259570
2025-01-27 8-K form8-k.htm 8.01,9.01 0001493152-25-003707 001-40023 25555727 34 30250781 1 1
2024-12-23 S-1 forms-1.htm 0001493152-24-051873 333-284032 241574961 33 3212809
2024-11-27 8-K form8-k.htm 3.01 0001493152-24-047994 001-40023 241511001 34 200970 1 1
2024-11-21 8-K form8-k.htm 1.01,9.01 0001493152-24-047085 001-40023 241482368 34 421495 1 1
2024-11-14 10-Q form10-q.htm 0001493152-24-045892 001-40023 241462531 34 6444502 1 1
2024-10-21 4 xslF345X05/ownership.xml 0001493152-24-041855 6049
2024-10-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001042167-24-000067 005-32837 241376446 34 7066
2024-09-16 8-K form8-k.htm 5.02 0001493152-24-036381 001-40023 241301066 34 195584 1 1
2024-08-14 10-Q form10-q.htm 0001493152-24-032143 001-40023 241207215 34 25454005 1 1
2024-07-02 424B3 form424b3.htm 0001493152-24-026034 333-280326 241096451 33 316399
2024-06-28 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-06-28 17:30:00 9999999995-24-002019 333-280326 241087732 33 2047
2024-06-27 CORRESP filename1.htm 0001493152-24-025392 14269
2024-06-27 S-1/A forms-1a.htm 0001493152-24-025390 333-280326 241076818 33 669986
2024-06-27 8-K form8-k.htm 8.01,9.01 0001493152-24-025382 001-40023 241075870 34 247954 1 1
2024-06-26 8-K form8-k.htm 5.07 0001493152-24-025269 001-40023 241073644 34 219251 1 1
2024-06-24 UPLOAD filename1.pdf 0000000000-24-007140 333-280326 40625
2024-06-20 S-1 forms-1.htm 0001493152-24-024367 333-280326 241053880 33 906306
2024-06-17 DEFA14A formdefa14a.htm 0001493152-24-024128 001-40023 241048623 34 23459
2024-06-13 3 xslF345X02/ownership.xml 0001493152-24-023692 3260
2024-06-07 8-K form8-k.htm 5.02,9.01 0001493152-24-023195 001-40023 241030755 34 287962 1 1
2024-05-23 SC 13G/A AMENDMENT NO. 17 TO SCHEDULE 13G 0001683168-24-003805 005-32837 24980525 34 50602
2024-05-23 424B5 form424b5.htm 0001493152-24-021081 333-267870 24975112 33 390272
2024-05-23 8-K form8-k.htm 1.01,3.02,9.01 0001493152-24-021078 001-40023 24975106 34 942459 1 1
2024-05-15 10-Q form10-q.htm 0001493152-24-019970 001-40023 24952295 34 5355136 1 1
2024-04-30 8-K form8-k.htm 1.01,9.01 0001493152-24-017209 001-40023 24896715 34 244633 1 1
2024-04-29 ARS formars.pdf 0001493152-24-016976 001-40023 24890977 34 2276767
2024-04-29 DEFA14A formdefa14a.htm 0001493152-24-016962 001-40023 24890805 34 626437
2024-04-29 DEF 14A formdef14a.htm 0001493152-24-016949 001-40023 24890580 34 811986
2024-03-26 10-K form10-k.htm 0001493152-24-011332 001-40023 24784475 34 12020935 1 1
2024-02-14 SC 13G/A armistice-gtbp123123a1.htm 0001172661-24-001266 005-32837 24636278 34 90989
2024-02-01 8-K form8-k.htm 3.03,5.03,7.01,9.01 0001493152-24-004587 001-40023 24585785 34 257081 1 1
2023-12-21 8-K form8-k.htm 5.07 0001493152-23-045714 001-40023 231504992 34 206171 1 1
2023-12-04 8-K form8-k.htm 8.01,9.01 0001493152-23-043582 001-40023 231464071 34 221707 1 1
2023-11-06 DEFA14A formdefa14a.htm 0001493152-23-039588 001-40023 231380859 34 43581
2023-11-06 DEFA14A formdefa14a.htm 0001493152-23-039586 001-40023 231380843 34 858886
2023-11-06 DEF 14A formdef14a.htm 0001493152-23-039585 001-40023 231380829 34 785714
2023-11-01 10-Q form10-q.htm 0001493152-23-038957 001-40023 231366743 34 5754400 1 1
2023-10-27 PRE 14A formpre14a.htm 0001493152-23-038560 001-40023 231356448 34 2398663
2023-09-19 SC 13G SCHEDULE 13G 0001042167-23-000059 005-32837 231262956 34 6010
2023-08-22 8-K form8-k.htm 3.01 0001493152-23-029841 001-40023 231194132 34 214479 1 1
2023-08-15 4 xslF345X05/ownership.xml 0001493152-23-029061 4758
2023-08-15 4 xslF345X05/ownership.xml 0001493152-23-029059 8834
2023-08-07 10-Q form10-q.htm 0001493152-23-026973 001-40023 231145910 34 4985713 1 1
2023-07-05 8-K form8-k.htm 5.07 0001493152-23-023367 001-40023 231066786 34 215352 1 1
2023-06-21 4 xslF345X04/ownership.xml 0001493152-23-022059 5686
2023-05-15 10-Q form10-q.htm 0001493152-23-017492 001-40023 23923951 34 4721469 1 1
2023-05-05 DEFA14A formdefa14a.htm 0001493152-23-015669 001-40023 23895138 34 1327132
2023-05-05 DEFR14A formdefr14a.htm 0001493152-23-015668 001-40023 23895132 34 1330954
2023-05-04 3 xslF345X02/ownership.xml 0001493152-23-015482 3133
2023-05-04 8-K form8-k.htm 5.02,9.01 0001493152-23-015385 001-40023 23886794 34 250805 1 1
2023-05-01 DEF 14A formdef14a.htm 0001493152-23-015047 001-40023 23875356 34 1579276
2023-04-11 4 xslF345X04/ownership.xml 0001493152-23-011888 4754
2023-04-10 4 xslF345X04/ownership.xml 0001493152-23-011772 5577
2023-03-30 10-K form10-k.htm 0001493152-23-009812 001-40023 23781544 34 7176886 1 1
2023-02-28 8-K form8-k.htm 3.01 0001493152-23-006284 001-40023 23686873 34 207908 1 1
2023-02-14 SC 13G armistice-gtbp123122.htm 0001172661-23-001111 005-32837 23625932 34 90736
2023-02-01 4 xslF345X03/ownership.xml 0001493152-23-003230 5781
2023-02-01 4 xslF345X03/ownership.xml 0001493152-23-003227 5609
2023-02-01 4 xslF345X03/ownership.xml 0001493152-23-003226 5664
2023-02-01 4 xslF345X03/ownership.xml 0001493152-23-003224 5645
2023-01-04 8-K form8-k.htm 1.01,8.01,9.01 0001493152-23-000198 001-40023 23504307 34 1022586 1 1
2023-01-04 424B5 form424b5.htm 0001493152-23-000171 333-267870 23503930 33 433115
2022-12-13 8-K form8-k.htm 5.02 0001493152-22-035311 001-40023 221460051 34 204653 1 1
2022-11-09 8-K form8-k.htm 5.03,9.01 0001493152-22-031139 001-40023 221373525 34 407679 1 1
2022-10-31 10-Q form10-q.htm 0001493152-22-030019 001-40023 221347120 34 16886834 1 1
2022-10-20 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-10-20 17:00:00 9999999995-22-003098 333-267870 221322120 33 1998
2022-10-19 UPLOAD filename1.pdf 0000000000-22-011477 40400
2022-10-18 CORRESP filename1.htm 0001493152-22-028693 12549
2022-10-13 S-3 forms-3.htm 0001493152-22-028353 333-267870 221309646 33 335725
2022-10-12 8-K form8-k.htm 5.07 0001493152-22-028260 001-40023 221307206 34 208669 1 1
2022-10-04 DEFA14A formdefa14a.htm 0001493152-22-027570 001-40023 221292550 34 63966
2022-10-04 8-K form8-k.htm 8.01,9.01 0001493152-22-027568 001-40023 221292538 34 247279 1 1
2022-08-30 8-K form8-k.htm 1.01 0001493152-22-024422 001-40023 221215477 34 210116 1 1
2022-08-17 8-K/A form8-ka.htm 5.07 0001493152-22-023342 001-40023 221174947 34 216082 1 1
2022-08-17 DEF 14A formdef14a.htm 0001493152-22-023343 001-40023 221174944 34 644146
2022-08-15 10-Q form10-q.htm 0001493152-22-022629 001-40023 221162898 34 4462113 1 1
2022-07-25 S-8 forms-8.htm 0001493152-22-020256 333-266316 221103760 33 117042
2022-07-19 4 xslF345X03/ownership.xml 0001493152-22-019876 6903
2022-07-19 4 xslF345X03/ownership.xml 0001493152-22-019875 9901
2022-07-19 4 xslF345X03/ownership.xml 0001493152-22-019874 5532
2022-07-19 4 xslF345X03/ownership.xml 0001493152-22-019873 5375
2022-07-19 4 xslF345X03/ownership.xml 0001493152-22-019872 10375
2022-07-19 4 xslF345X03/ownership.xml 0001493152-22-019871 7625
2022-06-14 3 xslF345X02/ownership.xml 0001493152-22-016676 3217
2022-06-14 8-K form8-k.htm 5.07 0001493152-22-016671 001-40023 221013576 34 227228 1 1
2022-06-10 8-K form8-k.htm 5.02 0001493152-22-016394 001-40023 221007980 34 207037 1 1
2022-05-16 10-Q form10-q.htm 0001493152-22-013539 001-40023 22925843 34 5506016 1 1
2022-04-29 DEF 14A fromdef14a.htm 0001493152-22-011622 001-40023 22877261 34 568711
2022-04-19 PRE 14A frompre14a.htm 0001493152-22-010468 001-40023 22835751 34 577008
2022-03-28 10-K form10-k.htm 0001493152-22-007883 001-40023 22775656 34 36392328 1 1
2022-03-08 8-K form8-k.htm 5.02 0001493152-22-006294 001-40023 22721714 34 205636 1 1
2022-03-03 SC 13G/A AMENDMENT NO. 16 0001683168-22-001393 005-32837 22706535 34 97534
2022-02-18 3 PRIMARY DOCUMENT 0001654954-22-001862 3019
2022-02-18 8-K FORM 8-K 5.02,9.01 0001654954-22-001828 001-40023 22651005 34 148663 1 1
2022-02-14 4 FORM 4 0001654954-22-001643 7003
2022-02-14 4 PRIMARY DOCUMENT 0001654954-22-001635 5117
2022-02-14 4 PRIMARY DOCUMENT 0001654954-22-001631 5327
2022-02-14 3 FORM 3 0001654954-22-001629 2980
2022-02-14 3 PRIMARY DOCUMENT 0001654954-22-001627 3054
2022-02-14 3 PRIMARY DOCUMENT 0001654954-22-001625 2968
2022-01-28 SC 13G/A sc13ga110022002_01282022.htm 0000921895-22-000270 005-32837 22569764 34 200969
2022-01-26 UPLOAD filename1.pdf 0000000000-22-001040 40371
2022-01-18 SC 13G/A AMENDMENT NO. 6 TO SCHEDULE 13G 0001213900-22-002288 005-32837 22534203 34 31346
2021-12-29 CORRESP filename1.htm 0001654954-21-013592 33498
2021-12-29 10-Q/A PRIMARY DOCUMENT 0001654954-21-013591 001-40023 211529827 34 3569346 1 1
2021-12-23 8-K PRIMARY DOCUMENT 8.01 0001654954-21-013517 001-40023 211517572 34 142100 1 1
2021-12-21 8-K PRIMARY DOCUMENT 5.02 0001654954-21-013424 001-40023 211510336 34 140970 1 1
2021-12-15 UPLOAD filename1.pdf 0000000000-21-015007 46241
2021-11-26 8-K PRIMARY DOCUMENT 3.01 0001654954-21-012629 001-40023 211451310 34 144237 1 1
2021-11-12 4 PRIMARY DOCUMENT 0001654954-21-012057 13912
2021-11-12 3 PRIMARY DOCUMENT 0001654954-21-012056 6102
2021-11-10 10-Q FORM 10-Q 0001654954-21-011973 001-40023 211397808 34 3735526 1 1
2021-11-01 8-K PRIMARY DOCUMENT 8.01,9.01 0001654954-21-011550 001-40023 211365734 34 4266269 1 1
2021-10-07 4 FORM 4 0001654954-21-010887 10833
2021-10-07 3 PRIMARY DOCUMENT 0001654954-21-010885 2968
2021-09-23 8-K CURRENT REPORT 8.01,9.01 0001654954-21-010321 001-40023 211271284 34 3581759 1 1
2021-09-13 8-K CURRENT REPORT 8.01,9.01 0001654954-21-009965 001-40023 211248586 34 3290760 1 1
2021-08-23 10-Q FORM 10-Q 0001654954-21-009366 001-40023 211197353 34 3211411 1 1
2021-08-17 NT 10-Q NT 10-Q 0001654954-21-009134 001-40023 211181131 34 32108
2021-05-19 8-K CURRENT REPORT 7.01,9.01 0001654954-21-006018 001-40023 21938746 34 1170741
2021-05-17 10-Q QUARTERLY REPORT 0001654954-21-005897 001-40023 21931656 34 2501600 1
2021-04-29 8-K CURRENT REPORT 5.02,8.01 0001654954-21-004820 001-40023 21871792 34 29219
2021-04-27 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2021-04-27 17:00:00 9999999995-21-001585 333-255429 21861157 33 2013
2021-04-23 UPLOAD filename1.pdf 0000000000-21-005090 40466
2021-04-23 CORRESP filename1.htm 0001654954-21-004560 10069
2021-04-22 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001654954-21-004509,2021-04-22 9999999995-21-001533 333-251311 21846561 33 2026
2021-04-22 S-1 FORM S-1 0001654954-21-004510 333-255429 21843145 33 645331
2021-04-22 POS AM POS AM 0001654954-21-004509 333-251311 21843139 33 506525
2021-04-16 10-K ANNUAL REPORT 0001654954-21-004295 001-40023 21832329 34 4155051 1
2021-04-16 8-K CURRENT REPORT 4.02 0001654954-21-004293 001-40023 21832313 34 104585
2021-04-16 SC 13G/A bristol_13ga16.htm 0001683168-21-001451 005-32837 21830125 34 72466
2021-03-31 NT 10-K NT 10-K 0001654954-21-003655 001-40023 21794538 34 27244
2021-02-22 8-K CURRENT REPORT 3.02,5.03,9.01 0001654954-21-001950 001-40023 21659635 34 39730
2021-02-18 8-K CURRENT REPORT 3.02 0001654954-21-001802 001-40023 21647574 34 26841
2021-02-17 SC 13G sc13g10022gtbp_02172021.htm 0000921895-21-000488 005-32837 21644778 34 228934
2021-02-17 8-K CURRENT REPORT 3.02 0001654954-21-001785 001-40023 21644058 34 26544
2021-02-12 424B4 424B4 0001654954-21-001543 333-251311 21621945 33 2227998
2021-02-11 8-K CURRENT REPORT 1.01,9.01 0001654954-21-001479 001-40023 21616858 34 50332
2021-02-10 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2021-02-10 17:00:00 9999999995-21-000547 333-251311 21616432 33 2013
2021-02-10 S-1MEF S-1MEF 0001654954-21-001459 333-252973 21616292 33 143977
2021-02-10 CERT 8A_Cert_GTBP.pdf 0001354457-21-000205 001-40023 21611229 34 159498
2021-02-09 CORRESP filename1.htm 0001654954-21-001369 12670
2021-02-09 S-1/A S-1/A 0001654954-21-001333 333-251311 21604082 33 5042159 1
2021-02-09 8-K CURRENT REPORT 1.01,2.03,9.01 0001654954-21-001320 001-40023 21603220 34 524005
2021-02-08 SC 13G/A AMENDMENT NO. 15 0001683168-21-000429 005-32837 21601032 34 73378
2021-02-08 8-A12B 8-A12B 0001654954-21-001276 001-40023 21600222 34 24704
2021-02-08 CORRESP filename1.htm 0001654954-21-001273 11183
2021-02-08 S-1/A AMENDMENT NO 2 0001654954-21-001271 333-251311 21600059 33 5821199 1
2021-02-05 SC 13G/A AMENDMENT NO. 5 TO SCHEDULE 13G 0001213900-21-007007 005-32837 21594627 34 32420
2021-02-02 S-1/A AMENDMENT NO 1 0001654954-21-001056 333-251311 21578950 33 5216195 1
2021-02-02 8-K CURRENT REPORT 1.01,9.01 0001654954-21-001050 000-08092 21578627 34 64993
2021-01-19 8-K CURRENT REPORT 5.02 0001654954-21-000584 000-08092 21533998 34 30577
2021-01-14 DEF 14C PRIMARY DOCUMENT 0001654954-21-000479 000-08092 21529518 34 222446
2020-12-31 8-K CURRENT REPORT 4.01,9.01 0001654954-20-014090 000-08092 201429383 34 54639
2020-12-30 PRE 14C PRE 14C 0001654954-20-014028 000-08092 201426473 34 228207
2020-12-28 8-K CURRENT REPORT 1.01,2.03,3.02,9.01 0001654954-20-013901 000-08092 201414374 34 353173
2020-12-23 4 PRIMARY DOCUMENT 0001356710-20-000003 9456
2020-12-23 8-K CURRENT REPORT 1.01,2.03,9.01 0001654954-20-013851 000-08092 201409670 34 59916
2020-12-18 4 PRIMARY DOCUMENT 0001356710-20-000002 9457
2020-12-16 UPLOAD filename1.pdf 0000000000-20-012049 40504
2020-12-15 4 PRIMARY DOCUMENT 0001356710-20-000001 15488
2020-12-11 S-1 FORM S-1 0001654954-20-013481 333-251311 201384402 33 4768286 1
2020-11-19 424B3 424B3 0001654954-20-012706 333-239858 201327686 33 708773
2020-11-13 10-Q QUARTERLY REPORT 0001654954-20-012364 000-08092 201312364 34 2427540 1
2020-11-09 424B3 PRIMARY DOCUMENT 0001654954-20-012035 333-239858 201298594 33 514987
2020-11-09 8-K CURRENT REPORT 1.01,2.03,3.02,9.01 0001654954-20-012026 000-08092 201298352 34 480697
2020-11-04 424B3 424B3 0001654954-20-011845 333-239858 201287629 33 54267
2020-11-04 8-K CURRENT REPORT 1.01,9.01 0001654954-20-011842 000-08092 201287432 34 46153
2020-10-07 424B3 424B3 0001654954-20-010920 333-239858 201229533 33 370422
2020-10-06 8-K CURRENT REPORT 1.01,9.01 0001654954-20-010850 000-08092 201225586 34 368073
2020-09-22 424B3 424B3 0001654954-20-010331 333-239858 201189988 33 556969
2020-09-22 8-K CURRENT REPORT 1.01,2.03,3.02,9.01 0001654954-20-010329 000-08092 201189639 34 528735
2020-08-18 424B3 PROSPECTUS SUPPLEMENT 0001654954-20-009309 333-239858 201114440 33 816456
2020-08-18 10-Q/A AMENDED QUARTERLY REPORT 0001654954-20-009258 000-08092 201111049 34 2124787 1
2020-08-14 424B3 424B3 0001654954-20-009202 333-239858 201106698 33 631116
2020-08-14 10-Q QUARTERLY REPORT 0001654954-20-009193 000-08092 201106373 34 2096436 1
2020-07-30 424B3 PRIMARY DOCUMENT 0001654954-20-008209 333-239858 201063055 33 1728538
2020-07-28 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2020-07-28 16:00:00 9999999995-20-001942 333-239858 201055598 33 2024
2020-07-24 CORRESP filename1.htm 0001654954-20-007991 12406
2020-07-23 D/A xslFormDX01/primary_doc.xml 06b 0001654954-20-007958 021-368883 201044187 33 7044
2020-07-22 UPLOAD filename1.pdf 0000000000-20-006656 40559
2020-07-14 S-1 REGISTRATION STATEMENT 0001654954-20-007687 333-239858 201027602 33 4253628 1
2020-07-09 8-K CURRENT REPORT 1.01,3.02,9.01 0001654954-20-007499 000-08092 201020637 34 696358
2020-06-23 8-K CURRENT REPORT 1.01,9.01 0001654954-20-006903 000-08092 20982857 34 97423
2020-06-19 8-K CURRENT REPORT 1.01,2.03,3.02,9.01 0001654954-20-006839 000-08092 20975806 34 539340
2020-06-12 D xslFormDX01/primary_doc.xml 06b 0001654954-20-006561 021-368883 20960762 33 7104
2020-06-10 SC 13G SCHEDULE 13G 0001683168-20-001922 005-32837 20953561 34 73230
2020-06-04 4 PRIMARY DOCUMENT 0000939798-20-000007 4923
2020-05-29 8-K CURRENT REPORT 7.01 0001654954-20-006114 000-08092 20927957 34 28260
2020-05-18 SC 13G/A AMENDMENT NO. 13 0001683168-20-001655 005-32837 20889547 34 73043
2020-05-15 10-Q QUARTERLY REPORT 0001654954-20-005654 000-08092 20886138 34 3355620 1
2020-05-14 4 PRIMARY DOCUMENT 0000939798-20-000006 4945
2020-03-27 10-K ANNUAL REPORT 0001654954-20-003380 000-08092 20751729 34 3018132 1
2020-02-04 SC 13G/A AMENDMENT NO. 12 0001683168-20-000338 005-32837 20573077 34 72765
2020-01-16 SC 13G/A AMENDMENT NO. 4 TO SCHEDULE 13G 0001213900-20-001195 005-32837 20531314 34 31249
2019-11-14 10-Q QUARTERLY REPORT 0001654954-19-012975 000-08092 191219895 34 1761048 1
2019-10-02 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2019-10-02 16:00:00 9999999995-19-002230 333-233748 191134339 33 2024
2019-09-26 CORRESP filename1.htm 0000939798-19-000037 10583
2019-09-24 8-K CURRENT REPORT 1.01,9.01 0001654954-19-011042 000-08092 191109200 34 42429
2019-09-20 UPLOAD filename1.pdf 0000000000-19-013809 46302
2019-09-13 S-1 REGISTRATION STATEMENT 0001654954-19-010735 333-233748 191092683 33 4627025 1
2019-08-23 8-K CURRENT REPORT 1.01,3.02,9.01 0001654954-19-009972 000-08092 191049899 34 800032
2019-08-16 4 PRIMARY DOCUMENT 0000939798-19-000031 4663
2019-08-16 4 PRIMARY DOCUMENT 0000939798-19-000030 4684
2019-08-14 10-Q QUARTERLY REPORT 0001654954-19-009581 000-08092 191026612 34 1781080 1
2019-07-12 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2019-07-12 16:00:00 9999999995-19-001582 333-232261 19954019 33 2023
2019-07-11 S-1/A AMENDED REGISTRATION STATEMENT 0001654954-19-008149 333-232261 19950814 33 2009464
2019-07-08 CORRESP filename1.htm 0001654954-19-008000 13698
2019-07-02 UPLOAD filename1.pdf 0000000000-19-010589 40120
2019-06-21 S-1 REGISTRATION STATEMENT 0001654954-19-007544 333-232261 19911825 33 4487584 1
2019-05-24 8-K GTBP 8K ISSUANCE OF NOTES 1.01,3.02,9.01 0000939798-19-000027 000-08092 19851981 34 705078
2019-05-15 10-Q QUARTERLY REPORT 0001654954-19-006086 000-08092 19827830 34 1765245 1
2019-04-19 8-K GTBP 8-K ITEM 3.02 3.02 0000939798-19-000019 000-08092 19758114 34 12586
2019-04-05 8-K GTBP 8-K FILING OF CERTIFICATE OF DESIGNATION 5.03,9.01 0000939798-19-000017 000-08092 19735539 34 48750
2019-03-29 10-K ANNUAL REPORT 0001654954-19-003697 000-08092 19716590 34 3512369 1
2019-03-22 8-K GTBP 8-K RESIGNATION OF DIRECTORS AND APPOINTMENT OF CFO 5.02 0000939798-19-000012 000-08092 19700500 34 14679
2019-03-21 8-K GTBP 8-K ITEM 5.02 5.02 0000939798-19-000010 000-08092 19697192 34 14362
2019-03-19 4 PRIMARY DOCUMENT 0000939798-19-000008 4921
2019-03-11 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2019-03-11 15:00:00 9999999995-19-000413 333-229667 19673871 33 2023
2019-03-05 CORRESP filename1.htm 0001654954-19-002315 14122
2019-02-28 UPLOAD filename1.pdf 0000000000-19-003434 40266
2019-02-14 S-3 REGISTRATION STATEMENT 0001654954-19-001492 333-229667 19600526 33 513904
2019-02-13 SC 13G/A AMENDMENT NO. 3 TO SCHEDULE 13G 0001213900-19-002332 005-32837 19596479 34 48295
2019-02-13 424B3 PROSPECTUS SUPPLEMENT 0001654954-19-001436 333-223349 19595568 33 622893
2019-02-13 4 PRIMARY DOCUMENT 0000939798-19-000005 4826
2019-02-12 SC 13G/A SCHEDULE 13G AMENDMENT 0001683168-19-000333 005-32837 19587766 34 69994
2019-02-06 8-K CURRENT REPORT 1.01,2.03,3.02,9.01 0001654954-19-001122 000-08092 19571526 34 964037
2019-02-05 SC 13G/A SC 13G/A2 JAMES W HEAVENER 0000939798-19-000004 005-32837 19567609 34 45876
2019-01-29 SC 13G/A SC 13G/A JAMES W HEAVENER 0000939798-19-000002 005-32837 19548452 34 44588
2019-01-07 8-K CURRENT REPORT 5.02 0001654954-19-000216 000-08092 19514037 34 27553
2019-01-07 8-K CURRENT REPORT 8.01,9.01 0001654954-19-000166 000-08092 19512232 34 3034331
2018-11-15 8-K CURRENT REPORT 2.02,9.01 0001654954-18-012790 000-08092 181185989 34 180875
2018-11-14 10-Q QUARTERLY REPORT 0001654954-18-012574 000-08092 181179918 34 3828747 1
2018-11-01 8-K CURRENT REPORT 8.01,9.01 0001654954-18-011827 000-08092 181152280 34 235051
2018-10-16 8-K CURRENT REPORT 5.01 0001654954-18-011231 000-08092 181124515 34 24146
2018-10-12 8-K CURRENT REPORT 5.02,9.01 0001654954-18-011065 000-08092 181120405 34 796793
2018-10-09 424B3 PROSPECTUS SUPPLEMENT 0001654954-18-010920 333-223349 181113840 33 596590
2018-09-28 8-K FORM 8-K 1.01,3.02,9.01 0001654954-18-010637 000-08092 181094140 34 488835
2018-09-21 424B3 424B3 0001654954-18-010380 333-223349 181081760 33 627482
2018-09-07 8-K CURRENT REPORT 1.01,3.02,9.01 0001654954-18-009975 000-08092 181060707 34 504986
2018-08-17 D xslFormDX01/primary_doc.xml 06b 0001654954-18-009332 021-319563 181026218 33 10770
2018-08-14 10-Q QUARTERLY REPORT 0001654954-18-009126 000-08092 181017798 34 1893112 1
2018-08-03 8-K CURRENT REPORT 1.01,3.02,9.01 0001654954-18-008406 000-08092 18990532 34 473872
2018-08-03 424B3 424B3 0001654954-18-008404 333-223349 18990507 33 651188
2018-07-05 8-K CURRENT REPORT 1.01,5.02,9.01 0001654954-18-007335 000-08092 18938730 34 102436
2018-05-15 10-Q QUARTERLY REPORT 0001654954-18-005412 000-08092 18836152 34 1703716 1
2018-05-14 8-K CURRENT REPORT 5.02,9.01 0001654954-18-005218 000-08092 18830516 34 37720
2018-04-27 8-K CURRENT REPORT 5.02,9.01 0001654954-18-004445 000-08092 18783727 34 59310
2018-03-22 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2018-03-22 14:00:00 9999999995-18-000654 333-223348 18708265 33 2007
2018-03-22 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2018-03-22 14:00:00 9999999995-18-000655 333-223349 18708258 33 2007
2018-03-21 CORRESP filename1.htm 0001654954-18-002887 12761
2018-03-21 CORRESP filename1.htm 0001654954-18-002886 13005
2018-03-21 S-3/A FORM S-3/A 0001654954-18-002882 333-223349 18704792 33 704826
2018-03-21 S-3/A FORM S-3/A 0001654954-18-002883 333-223348 18704791 33 491000
2018-03-16 3 PRIMARY DOCUMENT 0001654954-18-002717 3134
2018-03-15 S-3/A PRIMARY DOCUMENT 0001654954-18-002605 333-223349 18692534 33 705145
2018-03-15 CORRESP filename1.htm 0001654954-18-002607 19360
2018-03-15 S-3/A AMENDMENT TO REGISTRATION STATEMENT 0001654954-18-002600 333-223348 18692481 33 490733
2018-03-15 8-K/A CURRENT REPORT 5.03,9.01 0001654954-18-002596 000-08092 18692412 34 326208
2018-03-12 UPLOAD filename1.pdf 0000000000-18-007658 47460
2018-03-12 UPLOAD filename1.pdf 0000000000-18-007657 47460
2018-03-01 10-K ANNUAL REPORT 0001654954-18-002054 000-08092 18657445 34 3452369 1
2018-03-01 S-3 FORM S-3 0001654954-18-002052 333-223349 18657354 33 775038
2018-03-01 S-3 REGISTRATION STATEMENT 0001654954-18-002051 333-223348 18657328 33 512468
2018-02-28 10-K/A FORM 10-K/A 0001654954-18-001973 000-08092 18652449 34 2964739 1
2018-02-28 10-Q/A FORM 10-Q/A 0001654954-18-001972 000-08092 18652419 34 2001314 1
2018-02-28 10-Q/A FORM 10-Q/A 0001654954-18-001971 000-08092 18652394 34 1949323 1
2018-02-28 10-Q/A FORM 10-Q/A 0001654954-18-001970 000-08092 18652358 34 1844629 1
2018-02-28 10-K/A FORM 10-K/A 0001654954-18-001969 000-08092 18652312 34 2904248 1
2018-02-21 8-K CURRENT REPORT 1.01,4.02,5.02,9.01 0001654954-18-001758 000-08092 18629223 34 273650
2018-02-07 SC 13G/A SCHEDULE 13G AMENDMENT 0001683168-18-000342 005-32837 18581749 34 70144
2018-02-06 D xslFormDX01/primary_doc.xml 06b 0001654954-18-001133 021-304968 18578615 33 8299
2018-01-23 8-K CURRENT REPORT 1.01,3.02,9.01 0001654954-18-000646 000-08092 18542125 34 1208625
2018-01-16 8-K CURRENT REPORT 5.02,9.01 0001654954-18-000387 000-08092 18527339 34 40209
2017-12-04 SC 13G SCHEDULE 13G MARK J SILVERMAN 0000939798-17-000104 005-32837 171235278 34 45099
2017-12-01 4 PRIMARY DOCUMENT 0000939798-17-000102 9063
2017-12-01 3 PRIMARY DOCUMENT 0000939798-17-000101 3761
2017-12-01 3 PRIMARY DOCUMENT 0000939798-17-000100 3760
2017-12-01 4 PRIMARY DOCUMENT 0000939798-17-000099 4657
2017-12-01 3 PRIMARY DOCUMENT 0000939798-17-000098 3679
2017-11-16 8-K PRIMARY DOCUMENT 5.02,9.01 0001654954-17-010766 000-08092 171206713 34 121892
2017-11-14 10-Q QUARTERLY REPORT 0001654954-17-010615 000-08092 171201354 34 3352981 1
2017-11-14 SC 13G THEOREM GROUP LLC 13G FOR GT BIOPHARMA, INC. 0000939798-17-000081 005-32837 171198993 34 45046
2017-10-12 8-K CURRENT REPORT 1.01,9.01 0001654954-17-009357 000-08092 171134382 34 36278
2017-10-10 SC 13G/A AMENDMENT NO. 9 0001683168-17-002609 005-32837 171128738 34 66626
2017-09-20 SC 13G/A AMENDMENT NO. 2 TO SCHEDULE 13G 0001213900-17-009849 005-32837 171093525 34 38613
2017-09-14 D xslFormDX01/primary_doc.xml 06b 0000939798-17-000077 021-294767 171086166 33 8095
2017-09-05 8-K CURRENT REPORT 1.01,2.01,3.02,5.02 0001654954-17-008123 000-08092 171067497 34 34257
2017-08-11 10-Q QUARTERLY REPORT 0001654954-17-007377 000-08092 171025740 34 2506459 1
2017-07-25 8-K GT BIOPHARMA 8-K 5.03,8.01 0000939798-17-000063 000-08092 17979466 34 6187115 1 1
2017-07-24 RW OXIS WITHDRAWAL OF REGISTRATION STATEMENT 0000939798-17-000060 333-213270 17977853 NE 9950
2017-06-26 8-K PRIMARY DOCUMENT 7.01,9.01 0001654954-17-005850 000-08092 17928895 34 40776
2017-05-12 DEF 14C OXIS DEF 14C 0000939798-17-000048 000-08092 17838477 34 77379
2017-05-09 UPLOAD filename1.pdf 0000000000-17-016257 35761
2017-05-05 PRER14C OXIS PRE14C REVISION 3 0000939798-17-000044 000-08092 17819549 34 77283
2017-04-28 10-Q QUARTERLY REPORT 0001654954-17-003780 000-08092 17795756 34 1761544 1
2017-04-24 PRER14C OXIS PRE 14C REVISION 2 0000939798-17-000042 000-08092 17779111 34 83067
2017-04-20 UPLOAD filename1.pdf 0000000000-17-013706 38634
2017-04-14 PRER14C OXIS REVISED PRE 14C 0000939798-17-000039 000-08092 17762535 34 88089
2017-04-06 UPLOAD filename1.pdf 0000000000-17-011848 137257
2017-04-03 8-K OXIS 8-K ITEM 8.01 8.01 0000939798-17-000037 000-08092 17735111 34 12338
2017-03-31 10-K ANNUAL REPORT 0001654954-17-002919 000-08092 17730378 34 2817963 1
2017-03-24 PRE 14C OXIS PRE 14C TO EFFECT REVERSE SPLIT AND INCREASE AUTHORIZED SHARES 0000939798-17-000033 000-08092 17713431 34 74566
2017-03-23 8-K OXIS 8K ISSUANCE OF STOCK 3.02 0000939798-17-000031 000-08092 17710471 34 12508
2017-03-02 8-K OXIS 8-K STOCK ISSUANCE 3.02 0000939798-17-000029 000-08092 17659547 34 12933
2017-02-17 8-K OXIS 8-K ISSUANCE OF SECURITIES 3.02 0000939798-17-000026 000-08092 17622344 34 12532
2017-02-13 SC 13G/A AMENDMENT NO. 1 TO SCHEDULE 13G 0001213900-17-001248 005-32837 17597843 34 64822
2017-02-10 S-1/A OXIS S-1 AMENDMENT NO. 7 0000939798-17-000020 333-213270 17594712 33 1287084
2017-02-10 SC 13G/A SC 13G/A 0001683168-17-000290 005-32837 17594226 34 66118
2017-02-09 8-K OXIS 8-K ISSUANCE OF UNREGISTERED SHARES 3.02 0000939798-17-000018 000-08092 17588469 34 12533
2017-02-03 8-K OXIS 8-K ISSUANCE OF STOCK 3.02 0000939798-17-000016 000-08092 17572728 34 12509

Latest XBRL company facts

One latest value per concept from companyfacts (416 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 2.14M 2026-11-10 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
dei EntityListingParValuePerShare Entity Listing, Par Value Per Share USD/shares 0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001493152-26-008443
dei EntityPublicFloat Entity Public Float USD 8.60M 2025-06-30 2025 FY 10-K 2026-03-02 0001493152-26-008443
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 682,810 2025-01-01 2025-12-31 DEF 14A 2026-07-02 0001493152-26-031922
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 739,310 2025-01-01 2025-12-31 DEF 14A 2026-07-02 0001493152-26-031922
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 1.61M 2025-01-01 2025-12-31 DEF 14A 2026-07-02 0001493152-26-031922
ecd PeoTotalCompAmt PeoTotalCompAmt USD 1.73M 2025-01-01 2025-12-31 DEF 14A 2026-07-02 0001493152-26-031922
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 2.95 2025-01-01 2025-12-31 DEF 14A 2026-07-02 0001493152-26-031922
ffd NetFeeAmt NetFeeAmt USD 7,028.86 2026-10-09 S-1 2026-10-09 0001493152-26-046618
ffd TtlFeeAmt TtlFeeAmt USD 7,060.23 2026-10-09 S-1 2026-10-09 0001493152-26-046618
ffd TtlOfferingAmt TtlOfferingAmt USD 81.15M 2026-10-09 S-1 2026-10-09 0001493152-26-046618
ffd TtlOffsetAmt TtlOffsetAmt USD 31.37 2026-10-09 S-1 2026-10-09 0001493152-26-046618
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-10-09 S-1 2026-10-09 0001493152-26-046618
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 1.08M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap AccountsPayableInterestBearingInterestRate Accounts Payable, Interest-bearing, Interest Rate pure 1 2025-09-30 2025 Q3 10-Q/A 2026-03-06 0001493152-26-009126
us-gaap AccountsPayableOtherCurrent Accounts Payable, Other, Current USD 554,000 2025-03-31 2025 Q1 10-Q 2025-05-15 0001641172-25-010790
us-gaap AccountsPayableRelatedPartiesCurrent Accounts Payable, Related Parties, Current USD 2.28M 2022-12-31 2022 FY 10-K 2023-03-30 0001493152-23-009812
us-gaap AccountsPayableTradeCurrent Accounts Payable, Trade, Current USD 842,000 2024-06-30 2024 Q2 10-Q 2024-08-14 0001493152-24-032143
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 0 2014-12-31 2014 FY 10-K 2015-03-31 0001513160-15-000022
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 1.68M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 95,000 2019-12-31 2019 FY 10-K 2020-03-27 0001654954-20-003380
us-gaap AccruedRentCurrent Accrued Rent, Current USD 52,000 2019-12-31 2019 FY 10-K 2020-03-27 0001654954-20-003380
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 742.81M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD -559.63M 2020-09-30 2020 FY 10-K 2021-04-16 0001654954-21-004295
us-gaap AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD -4.52M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-30 0001493152-23-009812
us-gaap AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt USD 5.27M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-28 0001493152-22-007883
us-gaap AdjustmentsToAdditionalPaidInCapitalMarkToMarket Adjustments to Additional Paid in Capital, Fair Value USD 3.03M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0001493152-23-009812
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 17.32M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions APIC, Share-based Payment Arrangement, Recognition and Exercise USD 18.62M 2021-02-01 2021-02-16 2021 Q2 10-Q/A 2021-12-29 0001654954-21-013591
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition USD 3.75M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0001654954-21-011973
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 138,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 4.50M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0001493152-23-009812
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 164,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001493152-26-037988
us-gaap AdvertisingExpense Advertising Expense USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-04-16 0001654954-21-004295
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 42,000 2016-01-01 2016-12-31 2016 FY 10-K/A 2018-02-28 0001654954-18-001973
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 317,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-28 0001493152-22-007883
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-27 0001654954-20-003380
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 1.14M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-27 0001654954-20-003380
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-01 0001654954-18-002054
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 17.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-04-16 0001654954-21-004295
us-gaap Assets Assets USD 4.32M 2025-09-30 2025 Q3 10-Q/A 2026-03-06 0001493152-26-009126
us-gaap AssetsCurrent Assets, Current USD 10.57M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 29.97M 2021-09-30 2021 Q3 10-Q 2021-11-10 0001654954-21-011973
us-gaap AssetsNoncurrent Assets, Noncurrent USD 92,000 2020-06-30 2020 Q2 10-Q/A 2020-08-18 0001654954-20-009258
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 12.85M 2023-12-31 2024 FY 10-K 2025-02-21 0001493152-25-007908
us-gaap AvailableForSaleDebtSecuritiesGrossUnrealizedLoss Debt Securities, Available-for-sale, Unrealized Loss USD 2,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-15 0001493152-24-019970
us-gaap BankOverdrafts Bank Overdrafts USD 1,000 2013-09-30 2013 Q3 10-Q 2014-12-17 0001513160-14-000083
us-gaap CapitalLeasesFutureMinimumPaymentsDue Capital Leases, Future Minimum Payments Due USD 149.00M 2019-09-30 2019 Q3 10-Q 2019-11-14 0001654954-19-012975
us-gaap CapitalLeasesFutureMinimumPaymentsDueCurrent Capital Leases, Future Minimum Payments Due, Next Twelve Months USD 17.00M 2019-09-30 2019 Q3 10-Q 2019-11-14 0001654954-19-012975
us-gaap CapitalLeasesFutureMinimumPaymentsDueInFiveYears Capital Leases, Future Minimum Payments Due in Five Years USD 8.74M 2021-06-30 2021 Q2 10-Q/A 2021-12-29 0001654954-21-013591
us-gaap CapitalLeasesFutureMinimumPaymentsDueInFourYears Capital Leases, Future Minimum Payments Due in Four Years USD 2.02M 2021-06-30 2021 Q2 10-Q/A 2021-12-29 0001654954-21-013591
us-gaap CapitalLeasesFutureMinimumPaymentsDueInThreeYears Capital Leases, Future Minimum Payments Due in Three Years USD 2.46M 2021-06-30 2021 Q2 10-Q/A 2021-12-29 0001654954-21-013591
us-gaap CapitalLeasesFutureMinimumPaymentsDueInTwoYears Capital Leases, Future Minimum Payments Due in Two Years USD 2.46M 2021-06-30 2021 Q2 10-Q/A 2021-12-29 0001654954-21-013591
us-gaap CapitalLeasesFutureMinimumPaymentsDueThereafter Capital Leases, Future Minimum Payments Due Thereafter USD 591,000 2021-06-30 2021 Q2 10-Q/A 2021-12-29 0001654954-21-013591
us-gaap CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear Capital Leases, Future Minimum Payments, Remainder of Fiscal Year USD 81,000 2018-03-31 2018 Q1 10-Q 2018-05-15 0001654954-18-005412
us-gaap CapitalUnitsAuthorized Capital Units, Authorized shares 26.50M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap Cash Cash USD 10.00M 2023-12-31 2023 FY 10-K 2024-03-26 0001493152-24-011332
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 6.50M 2023-01-04 2023 Q2 10-Q 2023-08-07 0001493152-23-026973
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 9.92M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 34.21M 2021-01-01 2021-06-30 2021 Q2 10-Q/A 2021-12-29 0001654954-21-013591
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 9.20M 2024-06-30 2024 Q2 10-Q 2024-08-14 0001493152-24-032143
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 10.02M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 8.97M 2021-12-31 2021 FY 10-K 2022-03-28 0001493152-22-007883
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 3.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 8.30M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap CashUninsuredAmount Cash, Uninsured Amount USD 100,000 2020-09-30 2020 Q3 10-Q 2020-11-13 0001654954-20-012364
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 70.94 2025-02-26 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 846 2025-02-26 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 16,000 2026-04-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 25.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 2.06M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 2.06M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap CommonStockSharesSubscribedButUnissued Common Stock, Shares Subscribed but Unissued shares 3.15M 2021-06-30 2021 Q2 10-Q/A 2021-12-29 0001654954-21-013591
us-gaap CommonStockValue Common Stock, Value, Issued USD 2,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 2,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-30 0001493152-23-009812
us-gaap ConversionOfStockAmountIssued1 Conversion of Stock, Amount Issued USD 96,000 2025-01-01 2025-06-30 2026 Q2 10-Q 2026-08-14 0001493152-26-037988
us-gaap ConversionOfStockSharesConverted1 Conversion of Stock, Shares Converted shares 1.63M 2021-02-15 2021-02-16 2022 Q2 10-Q 2022-08-15 0001493152-22-022629
us-gaap ConversionOfStockSharesIssued1 Conversion of Stock, Shares Issued shares 511,879 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-28 0001493152-22-007883
us-gaap ConvertibleDebt Convertible Debt USD 0 2017-12-31 2017 FY 10-K 2018-03-01 0001654954-18-002054
us-gaap ConvertibleDebtCurrent Convertible Debt, Current USD 26.30M 2020-12-31 2021 FY 10-K 2022-03-28 0001493152-22-007883
us-gaap ConvertibleDebtNoncurrent Convertible Debt, Noncurrent USD 0 2017-12-31 2017 FY 10-K 2018-03-01 0001654954-18-002054
us-gaap ConvertibleNotesPayable Convertible Notes Payable USD 2.50M 2020-12-31 2022 Q2 10-Q 2022-08-15 0001493152-22-022629
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 30.82M 2020-12-31 2021 FY 10-K 2022-03-28 0001493152-22-007883
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 0 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-14 0001654954-18-009126
us-gaap CostOfRevenue Cost of Revenue USD 0 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-15 0001654954-20-005654
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 38.80M 2021-02-15 2021-02-16 2022 Q2 10-Q 2022-08-15 0001493152-22-022629
us-gaap DebtConversionConvertedInstrumentRate Debt Conversion, Converted Instrument, Rate pure 0.034 2021-02-15 2021-02-16 2022 Q2 10-Q 2022-08-15 0001493152-22-022629
us-gaap DebtConversionConvertedInstrumentSharesIssued1 Debt Conversion, Converted Instrument, Shares Issued shares 11.09M 2021-01-01 2021-12-31 2022 Q2 10-Q 2022-08-15 0001493152-22-022629
us-gaap DebtInstrumentConvertibleBeneficialConversionFeature Debt Instrument, Convertible, Beneficial Conversion Feature USD 4.75M 2020-01-01 2020-12-31 2020 FY 10-K 2021-04-16 0001654954-21-004295
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 3.4 2021-09-30 2021 Q3 10-Q 2021-11-10 0001654954-21-011973
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 33.27M 2021-09-30 2021 Q3 10-Q 2021-11-10 0001654954-21-011973
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 4.52M 2020-12-31 2021 FY 10-K 2022-03-28 0001493152-22-007883
us-gaap DebtInstrumentUnamortizedDiscountCurrent Debt Instrument, Unamortized Discount, Current USD 4.52M 2020-12-31 2020 FY 10-K 2021-04-16 0001654954-21-004295
us-gaap DebtInstrumentUnamortizedDiscountNoncurrent Debt Instrument, Unamortized Discount, Noncurrent USD 4.52M 2020-12-31 2021 FY 10-K 2022-03-28 0001493152-22-007883
us-gaap DebtSecuritiesAvailableForSaleRealizedGain Debt Securities, Available-for-sale, Realized Gain USD 48,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-21 0001493152-25-007908
us-gaap DebtSecuritiesAvailableForSaleRealizedGainLoss Debt Securities, Available-for-sale, Realized Gain (Loss) USD 18.37M 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-15 0001493152-22-022629
us-gaap DebtSecuritiesAvailableForSaleRealizedLoss Debt Securities, Available-for-sale, Realized Loss USD -30,000 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-15 0001493152-22-022629
us-gaap DebtSecuritiesAvailableForSaleUnrealizedGainLoss Debt Securities, Available-for-sale, Unrealized Gain (Loss) USD 12.89M 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-21 0001493152-25-007908
us-gaap DebtSecuritiesGainLoss Debt Securities, Gain (Loss) USD 533,000 2023-03-13 2024 Q1 10-Q 2024-05-15 0001493152-24-019970
us-gaap DebtSecuritiesUnrealizedGainLoss Debt Securities, Unrealized Gain (Loss) USD -1,000 2024-01-01 2024-09-30 2025 Q3 10-Q/A 2026-03-06 0001493152-26-009126
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 126,000 2018-06-30 2018 Q2 10-Q 2018-08-14 0001654954-18-009126
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 444,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap DeferredRentCreditCurrent Deferred Rent Credit, Current USD 0 2019-12-31 2019 FY 10-K 2020-03-27 0001654954-20-003380
us-gaap DeferredTaxAssetsCapitalLossCarryforwards Deferred Tax Assets, Capital Loss Carryforwards USD 13.49M 2012-12-31 2012 FY 10-K 2014-11-18 0001513160-14-000064
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 57.10M 2025-12-31 2025 FY 10-K 2026-03-02 0001493152-26-008443
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 141.11M 2025-12-31 2025 FY 10-K 2026-03-02 0001493152-26-008443
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 2.72M 2025-12-31 2025 FY 10-K 2026-03-02 0001493152-26-008443
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2020-12-31 2020 FY 10-K 2021-04-16 0001654954-21-004295
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 39.34M 2020-12-31 2020 FY 10-K 2021-04-16 0001654954-21-004295
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 73.33M 2025-12-31 2025 FY 10-K 2026-03-02 0001493152-26-008443
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 0 2020-12-31 2020 FY 10-K 2021-04-16 0001654954-21-004295
us-gaap DeferredTaxAssetsOtherLossCarryforwards Deferred Tax Assets, Other Loss Carryforwards USD 0 2017-12-31 2017 FY 10-K 2018-03-01 0001654954-18-002054
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 58.50M 2020-12-31 2020 FY 10-K 2021-04-16 0001654954-21-004295
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits USD 7.96M 2025-12-31 2025 FY 10-K 2026-03-02 0001493152-26-008443
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 4.78M 2020-12-31 2020 FY 10-K 2021-04-16 0001654954-21-004295
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 141.11M 2025-12-31 2025 FY 10-K 2026-03-02 0001493152-26-008443
us-gaap Deposits Deposits USD -9,000 2017-09-30 2017 Q3 10-Q 2017-11-14 0001654954-17-010615
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 9,000 2022-12-31 2023 FY 10-K 2024-03-26 0001493152-24-011332
us-gaap Depreciation Depreciation USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-04-16 0001654954-21-004295
us-gaap DerivativeAssets Derivative Asset USD 3.94M 2021-09-30 2021 Q3 10-Q 2021-11-10 0001654954-21-011973
us-gaap DerivativeFairValueOfDerivativeLiability Derivative Liability, Fair Value, Gross Liability USD 30,000 2021-12-31 2022 FY 10-K 2023-03-30 0001493152-23-009812
us-gaap DerivativeFixedInterestRate Derivative, Fixed Interest Rate pure 0.02 2010-11-08 2021 FY 10-K 2022-03-28 0001493152-22-007883
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD 119,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0001493152-23-009812
us-gaap DerivativeGainOnDerivative Derivative, Gain on Derivative USD 120,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0001493152-23-009812
us-gaap DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net USD -94,000 2012-01-01 2012-12-31 2012 FY 10-K 2014-11-18 0001513160-14-000064
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 394,000 2024-03-31 2024 Q1 10-Q 2024-05-15 0001493152-24-019970
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 1.10M 2023-09-30 2023 Q3 10-Q 2023-11-01 0001493152-23-038957
us-gaap DerivativeLossOnDerivative Derivative, Loss on Derivative USD 230,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-28 0001493152-22-007883
us-gaap DividendsPayableCurrent Dividends Payable, Current USD 144,000 2025-09-30 2025 Q3 10-Q/A 2026-03-06 0001493152-26-009126
us-gaap DividendsPreferredStock Dividends, Preferred Stock USD 39,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap DividendsPreferredStockStock Dividends, Preferred Stock, Stock USD 229,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap DueToRelatedPartiesCurrentAndNoncurrent Due to Related Parties USD 28.08M 2021-06-30 2021 Q2 10-Q/A 2021-12-29 0001654954-21-013591
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -7.61 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -2.06 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-28 0001493152-22-007883
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -7.61 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001493152-26-008443
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001493152-26-008443
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.29 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0001493152-23-009812
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.04 2013-01-01 2013-12-31 2013 FY 10-K 2015-01-08 0001513160-15-000005
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001493152-26-008443
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.07 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001493152-26-008443
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 245,000 2019-12-31 2019 FY 10-K 2020-03-27 0001654954-20-003380
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD -11,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap FairValueAssumptionsExpectedVolatilityRate Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) pure 0.9 2015-01-01 2015-12-31 2015 FY 10-K/A 2018-02-28 0001654954-18-001969
us-gaap FairValueAssumptionsRiskFreeInterestRate Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) pure 0.015 2015-01-01 2015-12-31 2015 FY 10-K/A 2018-02-28 0001654954-18-001969
us-gaap FairValueAssumptionsWeightedAverageExpectedDividend Fair Value Assumptions, Weighted Average Expected Dividend (Deprecated 2018-01-31) USD 0 2015-01-01 2015-12-31 2015 FY 10-K/A 2018-02-28 0001654954-18-001969
us-gaap FairValueNetAssetLiability Fair Value, Net Asset (Liability) USD 3.75M 2024-12-31 2024 FY 10-K 2025-02-21 0001493152-25-007908
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Earnings USD 0 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-29 0001654954-19-003697
us-gaap FinancialLiabilitiesFairValueDisclosure Financial Liabilities Fair Value Disclosure USD 11,000 2025-12-31 2025 FY 10-K 2026-03-02 0001493152-26-008443
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 642,000 2015-12-31 2015 FY 10-K/A 2018-02-28 0001654954-18-001969
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 4,000 2014-09-30 2014 Q3 10-Q 2015-01-08 0001513160-15-000011
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 4,000 2014-09-30 2014 Q3 10-Q 2015-01-08 0001513160-15-000011
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 4,000 2014-09-30 2014 Q3 10-Q 2015-01-08 0001513160-15-000011
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 4,000 2014-09-30 2014 Q3 10-Q 2015-01-08 0001513160-15-000011
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 4,000 2014-09-30 2014 Q3 10-Q 2015-01-08 0001513160-15-000011
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD -7,707 2012-12-31 2012 FY 10-K 2014-11-18 0001513160-14-000064
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 0 2015-12-31 2015 FY 10-K/A 2018-02-28 0001654954-18-001969
us-gaap FiniteLivedPatentsGross Finite-Lived Patents, Gross USD 642,000 2015-12-31 2015 FY 10-K/A 2018-02-28 0001654954-18-001969
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-04-16 0001654954-21-004295
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-04-16 0001654954-21-004295
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 0 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-13 0001654954-20-012364
us-gaap GainLossRelatedToLitigationSettlement Gain (Loss) Related to Litigation Settlement USD 5.38M 2020-01-01 2020-12-31 2020 FY 10-K 2021-04-16 0001654954-21-004295
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 200,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap Goodwill Goodwill USD 253.78M 2017-09-30 2017 Q3 10-Q 2017-11-14 0001654954-17-010615
us-gaap GrossProfit Gross Profit USD 0 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-15 0001654954-20-005654
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 0 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-13 0001654954-20-012364
us-gaap IncomeLossFromContinuingOperations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent USD 33.38M 2021-01-01 2021-06-30 2021 Q2 10-Q/A 2021-12-29 0001654954-21-013591
us-gaap IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest USD 0 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-15 0001654954-20-005654
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -13.36M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-13 0001654954-20-012364
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD 250,000 2010-11-01 2010-11-08 2021 Q2 10-Q/A 2021-12-29 0001654954-21-013591
us-gaap IncomeTaxesPaid Income Taxes Paid USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-04-16 0001654954-21-004295
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2021-01-01 2021-06-30 2021 Q2 10-Q/A 2021-12-29 0001654954-21-013591
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-13 0001654954-20-012364
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD -611,000 2021-01-01 2021-06-30 2021 Q2 10-Q/A 2021-12-29 0001654954-21-013591
us-gaap IncreaseDecreaseInAccountsPayableRelatedParties Increase (Decrease) in Accounts Payable, Related Parties USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-04-16 0001654954-21-004295
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 0 2016-01-01 2016-09-30 2016 Q3 10-Q/A 2018-02-28 0001654954-18-001972
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 689,000 2021-01-01 2021-06-30 2021 Q2 10-Q/A 2021-12-29 0001654954-21-013591
us-gaap IncreaseDecreaseInDeferredCompensation Increase (Decrease) in Deferred Compensation USD 7.89M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0001654954-21-011973
us-gaap IncreaseDecreaseInDerivativeLiabilities Increase (Decrease) in Derivative Liabilities USD -244,000 2025-01-01 2025-09-30 2025 Q3 10-Q/A 2026-03-06 0001493152-26-009126
us-gaap IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) USD -358,000 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-21 0001513160-12-000090
us-gaap IncreaseDecreaseInInterestPayableNet Increase (Decrease) in Interest Payable, Net USD 689,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-30 0001493152-23-009812
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-01 0001654954-18-002054
us-gaap IncreaseDecreaseInInventoriesAndOtherOperatingAssets Increase (Decrease) in Inventories and Other Operating Assets USD -12,000 2011-01-01 2011-12-31 2011 FY 10-K 2012-04-16 0001513160-12-000030
us-gaap IncreaseDecreaseInNotesPayableCurrent Increase (Decrease) in Notes Payable, Current USD 100,000 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001654954-17-010615
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -58,000 2024-01-01 2024-09-30 2025 Q3 10-Q/A 2026-03-06 0001493152-26-009126
us-gaap IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities USD 575,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -3,000 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-13 0001654954-20-012364
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-27 0001654954-20-003380
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -10,000 2011-01-01 2011-09-30 2011 Q3 10-Q 2011-11-21 0001513160-11-000069
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -814,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap IncreaseDecreaseInPrepaidExpensesOther Increase (Decrease) in Prepaid Expenses, Other USD 279,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0001654954-21-011973
us-gaap InsuranceCommissions Insurance Commissions USD 41,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-15 0001493152-26-023346
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 0 2020-06-30 2020 Q2 10-Q/A 2020-08-18 0001654954-20-009258
us-gaap IntangibleAssetsNetIncludingGoodwill Intangible Assets, Net (Including Goodwill) USD 0 2019-12-31 2019 FY 10-K 2020-03-27 0001654954-20-003380
us-gaap InterestAndDividendIncomeOperating Interest and Dividend Income, Operating USD 0 2014-01-01 2014-03-31 2014 Q1 10-Q 2015-01-08 0001513160-15-000009
us-gaap InterestExpense Interest Expense USD 212,000 2023-01-01 2023-03-31 2024 Q1 10-Q 2024-05-15 0001493152-24-019970
us-gaap InterestExpenseDebtExcludingAmortization Interest Expense, Debt, Excluding Amortization USD 696,000 2021-01-01 2021-09-30 2022 Q3 10-Q 2022-10-31 0001493152-22-030019
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 190,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD -638,000 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-15 0001654954-20-005654
us-gaap InterestIncomeOther Interest Income, Other USD 164,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 0 2021-01-01 2021-06-30 2021 Q2 10-Q/A 2021-12-29 0001654954-21-013591
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 213,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-21 0001493152-25-007908
us-gaap InterestPayableCurrent Interest Payable, Current USD 4.84M 2020-12-31 2021 FY 10-K 2022-03-28 0001493152-22-007883
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 0 2014-12-31 2014 FY 10-K 2015-03-31 0001513160-15-000022
us-gaap InventoryNet Inventory, Net USD 0 2014-12-31 2014 FY 10-K 2015-03-31 0001513160-15-000022
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 0 2014-12-31 2014 FY 10-K 2015-03-31 0001513160-15-000022
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 0 2014-12-31 2014 FY 10-K 2015-03-31 0001513160-15-000022
us-gaap InvestmentsAndCash Investments and Cash USD 19.90M 2023-03-31 2023 Q1 10-Q 2023-05-15 0001493152-23-017492
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 5.83M 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-21 0001493152-25-007908
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 50,000 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-13 0001654954-20-012364
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 30,000 2024-03-31 2024 Q1 10-Q 2024-05-15 0001493152-24-019970
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 60.00M 2023-12-31 2023 FY 10-K 2024-03-26 0001493152-24-011332
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 1,000 2022-12-31 2022 FY 10-K 2023-03-30 0001493152-23-009812
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 91,000 2022-12-31 2022 FY 10-K 2023-03-30 0001493152-23-009812
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 30,000 2024-03-31 2024 Q1 10-Q 2024-05-15 0001493152-24-019970
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 0 2024-03-31 2024 Q1 10-Q 2024-05-15 0001493152-24-019970
us-gaap Liabilities Liabilities USD 1.32M 2025-09-30 2025 Q3 10-Q/A 2026-03-06 0001493152-26-009126
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 10.57M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap LiabilitiesAssumed1 Liabilities Assumed USD 5.83M 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-21 0001493152-25-007908
us-gaap LiabilitiesCurrent Liabilities, Current USD 2.77M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 0 2017-12-31 2017 FY 10-K 2018-03-01 0001654954-18-002054
us-gaap LicenseAndServicesRevenue License and Services Revenue (Deprecated 2018-01-31) USD 0 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-15 0001654954-18-005412
us-gaap LineOfCredit Long-term Line of Credit USD 31,000 2021-12-31 2021 FY 10-K 2022-03-28 0001493152-22-007883
us-gaap LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity USD 300,000 2010-11-08 2021 FY 10-K 2022-03-28 0001493152-22-007883
us-gaap LineOfCreditFacilityRemainingBorrowingCapacity Line of Credit Facility, Remaining Borrowing Capacity USD 800,000 2010-11-08 2021 FY 10-K 2022-03-28 0001493152-22-007883
us-gaap LinesOfCreditCurrent Line of Credit, Current USD 31,000 2021-12-31 2022 FY 10-K 2023-03-30 0001493152-23-009812
us-gaap LitigationSettlementAmountAwardedToOtherParty Litigation Settlement, Amount Awarded to Other Party USD 0 2021-01-01 2021-06-30 2021 Q2 10-Q/A 2021-12-29 0001654954-21-013591
us-gaap LitigationSettlementExpense Litigation Settlement, Expense USD 425,000 2022-03-01 2022-03-04 2022 FY 10-K 2023-03-30 0001493152-23-009812
us-gaap LongDurationContractsAssumptionsByProductAndGuaranteeVolatilityRate Long-Duration Contracts, Assumptions by Product and Guarantee, Volatility Rate pure 1.35 2021-06-30 2021 Q2 10-Q/A 2021-12-29 0001654954-21-013591
us-gaap LossContingencyDamagesPaidValue Loss Contingency, Damages Paid, Value USD 150,000 2025-09-02 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap LossContingencyDamagesSoughtValue Loss Contingency, Damages Sought, Value USD 100,000 2025-09-02 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD 1,000 2024-01-01 2024-09-30 2025 Q3 10-Q/A 2026-03-06 0001493152-26-009126
us-gaap MinimumLeasePaymentsSaleLeasebackTransactions Minimum Lease Payments, Sale Leaseback Transactions USD 290,000 2022-01-01 2021 FY 10-K 2022-03-28 0001493152-22-007883
us-gaap MinimumLeasePaymentsSaleLeasebackTransactionsThereafter Minimum Lease Payments, Sale Leaseback Transactions, Thereafter USD 60,000 2022-01-01 2021 FY 10-K 2022-03-28 0001493152-22-007883
us-gaap MinimumLeasePaymentsSaleLeasebackTransactionsWithinOneYear Minimum Lease Payments, Sale Leaseback Transactions, Next Twelve Months USD 113,000 2022-01-01 2021 FY 10-K 2022-03-28 0001493152-22-007883
us-gaap MinimumLeasePaymentsSaleLeasebackTransactionsWithinTwoYears Minimum Lease Payments, Sale Leaseback Transactions, within Two Years USD 117,000 2022-01-01 2021 FY 10-K 2022-03-28 0001493152-22-007883
us-gaap MinorityInterest Stockholders' Equity Attributable to Noncontrolling Interest USD -169,000 2021-03-31 2021 Q1 10-Q 2021-05-17 0001654954-21-005897
us-gaap MinorityInterestOwnershipPercentageByNoncontrollingOwners Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners pure 0.4 2011-06-30 2012 Q2 10-Q/A 2012-09-13 0001513160-12-000065
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 12.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 12.89M 2024-01-01 2024-09-30 2025 Q3 10-Q/A 2026-03-06 0001493152-26-009126
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -9.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -10.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD 0 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-15 0001654954-19-006086
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -11.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap NoncontrollingInterestInVariableInterestEntity Noncontrolling Interest in Variable Interest Entity USD -169,000 2021-06-30 2021 Q2 10-Q/A 2021-12-29 0001654954-21-013591
us-gaap NoninterestExpenseOfferingCost Noninterest Expense Offering Cost USD 70,000 2025-02-26 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap NonoperatingGainsLosses Nonoperating Gains (Losses) USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-04-16 0001654954-21-004295
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -15,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap NotesIssued1 Notes Issued USD 1.52M 2021-01-01 2021-09-30 2022 Q3 10-Q 2022-10-31 0001493152-22-030019
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 500,000 2021-12-31 2021 FY 10-K 2022-03-28 0001493152-22-007883
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap OfficersCompensation Salary and Wage, Officer, Excluding Cost of Good and Service Sold USD 3.17M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0001654954-21-011973
us-gaap OperatingExpenses Operating Expenses USD 1.99M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-15 0001493152-26-023346
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -10.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap OperatingLeaseCost Operating Lease, Cost USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-04-16 0001654954-21-004295
us-gaap OperatingLeaseImpairmentLoss Operating Lease, Impairment Loss USD 4.60M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-14 0001654954-19-012975
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 30,000 2024-03-31 2024 Q1 10-Q 2024-05-15 0001493152-24-019970
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 58,000 2023-12-31 2024 FY 10-K 2025-02-21 0001493152-25-007908
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 64,000 2022-12-31 2023 FY 10-K 2024-03-26 0001493152-24-011332
us-gaap OperatingLeasePayments Operating Lease, Payments USD 30 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-15 0001493152-24-019970
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 53,000 2023-12-31 2024 FY 10-K 2025-02-21 0001493152-25-007908
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 53,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0001493152-24-045892
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 1.21M 2021-06-30 2021 Q2 10-Q/A 2021-12-29 0001654954-21-013591
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 71,000 2019-12-31 2019 FY 10-K 2020-03-27 0001654954-20-003380
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 61,000 2018-12-31 2018 FY 10-K 2019-03-29 0001654954-19-003697
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 61,000 2020-09-30 2020 Q3 10-Q 2020-11-13 0001654954-20-012364
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 18,000 2020-09-30 2020 Q3 10-Q 2020-11-13 0001654954-20-012364
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.1 2024-03-31 2024 Q1 10-Q 2024-05-15 0001493152-24-019970
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 260.00M 2025-12-31 2025 FY 10-K 2026-03-02 0001493152-26-008443
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 903,000 2024-06-30 2024 Q2 10-Q 2024-08-14 0001493152-24-032143
us-gaap OtherAssetsFairValueDisclosure Other Assets, Fair Value Disclosure USD 26.03M 2021-09-30 2021 Q3 10-Q 2021-11-10 0001654954-21-011973
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 84,000 2020-09-30 2020 Q3 10-Q 2020-11-13 0001654954-20-012364
us-gaap OtherCommitment Other Commitment USD 1.07M 2023-12-31 2023 FY 10-K 2024-03-26 0001493152-24-011332
us-gaap OtherCommitmentDueInFourthYear Other Commitment, to be Paid, Year Four USD 377,000 2021-12-31 2021 FY 10-K 2022-03-28 0001493152-22-007883
us-gaap OtherCommitmentDueInNextTwelveMonths Other Commitment, to be Paid, Year One USD 1.01M 2023-12-31 2023 FY 10-K 2024-03-26 0001493152-24-011332
us-gaap OtherCommitmentDueInSecondYear Other Commitment, to be Paid, Year Two USD 53,000 2023-12-31 2023 FY 10-K 2024-03-26 0001493152-24-011332
us-gaap OtherCommitmentDueInThirdYear Other Commitment, to be Paid, Year Three USD 1.01M 2021-12-31 2021 FY 10-K 2022-03-28 0001493152-22-007883
us-gaap OtherNoncashExpense Other Noncash Expense USD 0 2021-01-01 2021-06-30 2021 Q2 10-Q/A 2021-12-29 0001654954-21-013591
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD -3.97M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-13 0001654954-20-012364
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 1.16M 2021-01-01 2021-06-30 2021 Q2 10-Q/A 2021-12-29 0001654954-21-013591
us-gaap OtherNonoperatingGainsLosses Other Nonoperating Gains (Losses) USD 12.60M 2020-01-01 2020-12-31 2020 FY 10-K 2021-04-16 0001654954-21-004295
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 156,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 413,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-15 0001493152-26-023346
us-gaap PaymentsForProceedsFromInvestments Payments for (Proceeds from) Investments USD -12.89M 2024-01-01 2024-09-30 2025 Q3 10-Q/A 2026-03-06 0001493152-26-009126
us-gaap PaymentsForRent Payments for Rent USD 25,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-15 0001493152-24-019970
us-gaap PaymentsOfDividends Payments of Dividends USD 85,000 2025-01-01 2025-09-30 2025 Q3 10-Q/A 2026-03-06 0001493152-26-009126
us-gaap PaymentsOfLoanCosts Payments of Loan Costs USD 0 2020-01-01 2020-06-30 2020 Q2 10-Q/A 2020-08-18 0001654954-20-009258
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 1.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 6.99M 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-15 0001493152-23-017492
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 0 2020-01-01 2020-06-30 2020 Q2 10-Q/A 2020-08-18 0001654954-20-009258
us-gaap PreferredStockConvertibleConversionPrice PreferredStockConvertibleConversionPrice USD/shares 0.454 2026-06-30 2026 Q2 10-Q 2026-08-14 0001493152-26-037988
us-gaap PreferredStockDividendsIncomeStatementImpact Preferred Stock Dividends, Income Statement Impact USD 433,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 1.50M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 96,230 2023-12-31 2024 Q2 10-Q 2024-08-14 0001493152-24-032143
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 96,230 2023-12-31 2024 Q2 10-Q 2024-08-14 0001493152-24-032143
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 1,000 2025-12-31 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 107,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 222,000 2022-06-30 2022 Q2 10-Q 2022-08-15 0001493152-22-022629
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 1.20M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-28 0001493152-22-007883
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 6.27M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-26 0001493152-24-011332
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 4.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap ProceedsFromIssuanceOfMediumTermNotes Proceeds from Issuance of Medium-term Notes USD 1.21M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-30 0001493152-23-009812
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 686,000 2025-02-26 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 2.98M 2024-01-01 2024-09-30 2025 Q3 10-Q/A 2026-03-06 0001493152-26-009126
us-gaap ProceedsFromMinorityShareholders Proceeds from Noncontrolling Interests USD 0 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-13 0001654954-20-012364
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 1.20M 2021-01-01 2021-06-30 2021 Q2 10-Q/A 2021-12-29 0001654954-21-013591
us-gaap ProceedsFromSaleOfEquityMethodInvestments Proceeds from Sale of Equity Method Investments USD 3.53M 2022-01-01 2022-03-31 2023 Q1 10-Q 2023-05-15 0001493152-23-017492
us-gaap ProceedsFromSalesOfAssetsInvestingActivities Proceeds from Sales of Assets, Investing Activities USD 4.61M 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-15 0001493152-22-022629
us-gaap ProceedsFromShortTermDebt Proceeds from Short-term Debt USD 1.90M 2016-01-01 2016-09-30 2016 Q3 10-Q/A 2018-02-28 0001654954-18-001972
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-31 0001513160-15-000022
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 577,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap ProductWarrantyAccrualClassifiedCurrent Product Warranty Accrual, Current USD 0 2017-12-31 2017 FY 10-K 2018-03-01 0001654954-18-002054
us-gaap ProfessionalFees Professional Fees USD 473,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-21 0001493152-25-007908
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -800,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-15 0001641172-25-010790
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 0 2020-06-30 2020 Q2 10-Q/A 2020-08-18 0001654954-20-009258
us-gaap RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty Related Party Transaction, Expenses from Transactions with Related Party USD 250,000 2021-01-01 2021-06-30 2021 Q2 10-Q/A 2021-12-29 0001654954-21-013591
us-gaap RepaymentsOfConvertibleDebt Repayments of Convertible Debt USD 39,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-04-16 0001654954-21-004295
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 3.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 2.10M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-15 0001493152-24-019970
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 94,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -735.01M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap Revenues Revenues USD 0 2021-01-01 2021-06-30 2021 Q2 10-Q/A 2021-12-29 0001654954-21-013591
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 53.00M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-26 0001493152-24-011332
us-gaap SalariesAndWages Salary and Wage, NonOfficer, Excluding Cost of Good and Service Sold USD 361,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-15 0001493152-26-023346
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 4.95M 2021-01-01 2021-06-30 2021 Q2 10-Q/A 2021-12-29 0001654954-21-013591
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 5.5 2021-02-16 2021 Q2 10-Q/A 2021-12-29 0001654954-21-013591
us-gaap SalesRevenueGoodsNet Sales Revenue, Goods, Net (Deprecated 2018-01-31) USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-01 0001654954-18-002054
us-gaap SalesRevenueNet Revenue, Net (Deprecated 2018-01-31) USD 0 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-15 0001654954-18-005412
us-gaap SecuredDebtCurrent Secured Debt, Current USD 0 2017-12-31 2017 FY 10-K 2018-03-01 0001654954-18-002054
us-gaap SellingExpense Selling Expense USD 0 2013-01-01 2013-12-31 2013 FY 10-K 2015-01-08 0001513160-15-000005
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 7.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 46,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-15 0001493152-26-023346
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding USD 12,000 2024-03-31 2024 Q1 10-Q 2024-05-15 0001493152-24-019970
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Intrinsic Value, Amount Per Share USD/shares 3.4 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-01 0001493152-23-038957
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-29 0001654954-19-003697
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 1,037 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Intrinsic Value, Amount Per Share USD/shares 0.71 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-01 0001493152-23-038957
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 2 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-29 0001654954-19-003697
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 2,778 2024-03-31 2024 Q1 10-Q 2024-05-15 0001493152-24-019970
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 5.44 2021-03-31 2021 Q1 10-Q 2021-05-17 0001654954-21-005897
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-29 0001654954-19-003697
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.21 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-15 0001493152-24-019970
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.036 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-15 0001493152-24-019970
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised shares 60,953 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures shares 0 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-17 0001654954-21-005897
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations shares 6,886 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted shares 7.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number shares 9.39M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 12,000 2025-06-30 2025 Q2 10-Q/A 2026-03-06 0001493152-26-009127
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 22,169 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 111.28 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 7.40M 2025-01-01 2025-06-30 2025 Q2 10-Q/A 2026-03-06 0001493152-26-009127
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 52,050 2025-01-01 2025-09-30 2025 Q3 10-Q/A 2026-03-06 0001493152-26-009126
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 43.08 2025-01-01 2025-09-30 2025 Q3 10-Q/A 2026-03-06 0001493152-26-009126
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 3 2020-01-01 2020-12-31 2020 FY 10-K 2021-04-16 0001654954-21-004295
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 525,000 2025-01-01 2025-09-30 2025 Q3 10-Q/A 2026-03-06 0001493152-26-009126
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 23,335 2024-10-17 2024 FY 10-K 2025-02-21 0001493152-25-007908
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares shares 392,500 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-01 0001493152-23-038957
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 2.71M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 23,902 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 105.81 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 607,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 2.20M 2021-12-31 2021 FY 10-K 2022-03-28 0001493152-22-007883
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 105,802 2024-12-31 2024 FY 10-K 2025-02-21 0001493152-25-007908
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 915,273 2021-02-15 2021-02-16 2022 Q2 10-Q 2022-08-15 0001493152-22-022629
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award shares 126,515 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001493152-26-037988
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-04-16 0001654954-21-004295
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 2.81 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-01 0001493152-23-038957
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 1.33 2025-01-01 2025-09-30 2025 Q3 10-Q/A 2026-03-06 0001493152-26-009126
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price USD/shares 2.11 2024-10-17 2024 FY 10-K 2025-02-21 0001493152-25-007908
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable shares 45,000 2024-10-17 2024 FY 10-K 2025-02-21 0001493152-25-007908
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding shares 22,169 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price USD/shares 111.28 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap SharePrice Share Price USD/shares 1 2025-11-20 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap SharesIssued Shares, Issued shares 2.85M 2021-02-16 2022 Q2 10-Q 2022-08-15 0001493152-22-022629
us-gaap ShortTermInvestments Short-term Investments USD 12.89M 2023-12-31 2024 FY 10-K 2025-02-21 0001493152-25-007908
us-gaap StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants USD 164,000 2026-04-01 2026-04-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap StockGrantedDuringPeriodValueSharebasedCompensation Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture USD 500,000 2023-05-15 2023 Q3 10-Q 2023-11-01 0001493152-23-038957
us-gaap StockGrantedDuringPeriodValueSharebasedCompensationGross Shares Granted, Value, Share-based Payment Arrangement, before Forfeiture USD 269,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-28 0001493152-22-007883
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 7.80M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD -169,000 2016-09-30 2016 Q3 10-Q/A 2018-02-28 0001654954-18-001972
us-gaap StockIssued1 Stock Issued USD 164,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 3.15M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-13 0001654954-20-012364
us-gaap StockIssuedDuringPeriodSharesConversionOfUnits Stock Issued During Period, Shares, Conversion of Units shares 19,857 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-01 0001654954-18-002054
us-gaap StockIssuedDuringPeriodSharesIssuedForServices Stock Issued During Period, Shares, Issued for Services shares 189,753 2021-01-01 2021-06-30 2021 Q2 10-Q/A 2021-12-29 0001654954-21-013591
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 95.00M 2012-01-01 2012-06-30 2012 Q2 10-Q/A 2012-09-13 0001513160-12-000065
us-gaap StockIssuedDuringPeriodSharesOther Stock Issued During Period, Shares, Other shares 24,018 2025-05-12 2025 FY 10-K 2026-03-02 0001493152-26-008443
us-gaap StockIssuedDuringPeriodSharesShareBasedCompensation Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture shares 66,667 2023-01-27 2024 Q2 10-Q 2024-08-14 0001493152-24-032143
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 3.08M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0001654954-21-011973
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 96,000 2025-01-01 2025-06-30 2026 Q2 10-Q 2026-08-14 0001493152-26-037988
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 4.30M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001493152-26-037988
us-gaap StockIssuedDuringPeriodValueEmployeeBenefitPlan Stock Issued During Period, Value, Employee Benefit Plan USD 267,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-26 0001493152-24-011332
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 718,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 10.51M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001493152-26-008443
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 44,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 583,334 2025-01-01 2025-06-30 2025 Q2 10-Q/A 2026-03-06 0001493152-26-009127
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-31 0001513160-15-000022
us-gaap StockIssuedDuringPeriodValueShareBasedCompensationGross Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture USD 3.85M 2022-01-01 2022-09-30 2023 Q3 10-Q 2023-11-01 0001493152-23-038957
us-gaap StockRepurchasedAndRetiredDuringPeriodShares Stock Repurchased and Retired During Period, Shares shares 9,700 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-26 0001493152-24-011332
us-gaap StockRepurchasedDuringPeriodShares Stock Repurchased During Period, Shares shares 13,902 2024-05-01 2024-05-31 2024 FY 10-K 2025-02-21 0001493152-25-007908
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 19,000 2024-05-01 2024-05-31 2024 FY 10-K 2025-02-21 0001493152-25-007908
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 1.96M 2025-06-30 2025 Q2 10-Q/A 2026-03-06 0001493152-26-009127
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 13,902 2022-05-13 2024 FY 10-K 2025-02-21 0001493152-25-007908
us-gaap UnrealizedGainLossOnDerivatives Unrealized Gain (Loss) on Derivatives USD -43,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0001654954-21-011973
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 44,000 2025-05-31 2025 Q3 10-Q/A 2026-03-06 0001493152-26-009126
us-gaap WarrantsNotSettleableInCashFairValueDisclosure Warrants Not Settleable in Cash, Fair Value Disclosure USD 72,000 2012-06-30 2012 Q2 10-Q/A 2012-09-13 0001513160-12-000065
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 1.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 28.16M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-28 0001493152-22-007883
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 1.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052327

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →